Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Product and Service Type (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation Of Revenue [Line Items]
Revenues	$ 18,385	$ 14,255
Scilex Pharmaceuticals Inc. Product Sales
Disaggregation Of Revenue [Line Items]
Revenues	6,812	6,986
Sorrento Therapeutics, Inc. product revenues
Disaggregation Of Revenue [Line Items]
Revenues	3,178	37
Net Product Revenues
Disaggregation Of Revenue [Line Items]
Revenues	9,990	7,023
Concortis Biosystems Corporation
Disaggregation Of Revenue [Line Items]
Revenues	4,634	5,462
Bioserv Corporation
Disaggregation Of Revenue [Line Items]
Revenues	875	1,199
Other Service Revenues
Disaggregation Of Revenue [Line Items]
Revenues	2,886	571
Service Revenues
Disaggregation Of Revenue [Line Items]
Revenues	$ 8,395	$ 7,232